Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

NCT04078022 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Shigella

Interventions

BIOLOGICAL: SF2a-TT15 Shigella Vaccine
OTHER: Placebo
BIOLOGICAL: S. flexneri 2a strain 2457T Challenge Agent

Sponsor

University of Maryland, Baltimore